Clinical Trials Logo

Clinical Trial Summary

There are numerous reported ways to treat chronic subdural hematomas (CSDH) and practice is still differing considerably between departments. Except for a recent randomized controlled trial (RCT) that found that postoperative subdural drainage was better than no drain, there is no higher level evidence. Another recent RCT did not replicate these findings, but the study was severely underpowered.

Aim of this population based study is to compare clinical results (reoperation rates, complications, perioperative death, and survival) between neurosurgical departments treating CSDH with different treatment policies.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01930617
Study type Observational
Source St. Olavs Hospital
Contact
Status Completed
Phase N/A
Start date June 2014
Completion date December 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04742920 - The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS) N/A
Recruiting NCT05327933 - Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization N/A
Recruiting NCT05426889 - The Role of Meningeal Lymphatic Vessels in the Absorption of Chronic Subdural Hematoma and Its Injury Mechanism N/A
Recruiting NCT03582293 - Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma Phase 3
Terminated NCT00915928 - Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors N/A
Completed NCT03755349 - Covers to Improve Esthetic Outcome After Surgery for Chronic Subdural Hematoma N/A
Terminated NCT02362321 - Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma Phase 4
Recruiting NCT04573387 - Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy N/A
Withdrawn NCT03845322 - Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence Early Phase 1